Lutetium Lu 177 Dotatate Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 7.4 GBq/ vial
Reference Brands: Lutathera (USA, EU)
Category: Oncology Cancer Care
Lutathera is a radiolabeled peptide receptor radionuclide therapy (PRRT) used to treat gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that express somatostatin receptors. It works by delivering targeted radiation directly to tumor cells, minimizing damage to surrounding healthy tissue. The therapy is administered via intravenous infusion under specialized medical supervision, usually in cycles of four doses spaced eight weeks apart. Lutetium Lu 177 dotatate is available in Injection and strengths such as 7.4 GBq/ vial. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Lutetium Lu 177 dotatate is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Lutetium Lu 177 dotatate can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Lutetium Lu 177 dotatate is used to treat somatostatin receptor‑positive gastroenteropancreatic neuroendocrine tumors (GEP‑NETs) in adults and in children aged 12 years and older.
It is a radioconjugate composed of a somatostatin‑analog peptide (Tyr³‑octreotate, DOTA‑TATE) chelated to the radioisotope lutetium‑177.
The trade name is Lutathera.
It is manufactured by Advanced Accelerator Applications, a subsidiary of Novartis.
The generic name is Lutetium Lu 177 dotatate.
The brand name is Lutathera.
It is produced under Good Manufacturing Practice (GMP) by Advanced Accelerator Applications / Novartis, with facilities and supply chain managed internationally.
Related Products
Motixafortide Acetate
Strength:
1 mg/mL
Form: Injection
Reference Brands: Aphexda (USA)
View Details
Momelotinib
Strength:
100 mg, 150 mg, 200 mg
Form: Tablets
Reference Brands: Ojjaara (USA)
View Details
Nirogacestat
Strength:
50 mg
Form: Tablets
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers
